A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside

被引：14

作者：

Radi, Giulia ^{[1
]}

Campanti, Anna ^{[1
]}

Diotallevi, Federico ^{[1
]}

Martina, Emanuela ^{[1
]}

Marani, Andrea ^{[1
]}

Offidani, Annamaria ^{[1
]}

机构：

[1] Polytech Marche Univ, Dermatol Clin, Dept Clin & Mol Sci, I-60126 Ancona, Italy

来源：

BIOMEDICINES | 2022年 / 10卷 / 11期

关键词：

atopic dermatitis; pathophysiology; small molecules; biologics; novel treatments; DOUBLE-BLIND; EPIDERMAL BARRIER; BASIC SCIENCE; PLACEBO; PHASE-3; ADOLESCENTS; RECEPTORS; CYTOKINES; EFFICACY; ADULTS;

D O I：

10.3390/biomedicines10112700

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Atopic dermatitis (AD) is a common chronic inflammatory and immune-mediated skin disease with a complex pathophysiology and still represents a therapeutic challenge, owing to limited responses to available treatments. However, recent advances in the understanding of AD pathophysiology have led to the discovery of several new potential therapeutic targets, and research in the field of new molecules with therapeutic perspectives is boiling, with more than 70 new promising drugs in development. The aim of this systematic review is to provide the state of the art on the current knowledge concerning the pathophysiology of the disease and on novel agents currently being investigated for AD, and to highlight which type of evolution is going to take place in therapeutic approaches of atopic dermatitis in the coming years.

引用

页数：28

共 89 条

[1] Skin pH: From Basic Science to Basic Skin Care [J].

Ali, Saba M. ;

Yosipovitch, Gil .

ACTA DERMATO-VENEREOLOGICA, 2013, 93 (03) :261-267

[2] Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release [J].

Archer, Nathan K. ;

Jo, Jay-Hyun ;

Lee, Steven K. ;

Kim, Dongwon ;

Smith, Barbara ;

Ortines, Roger V. ;

Wang, Yu ;

Marchitto, Mark C. ;

Ravipati, Advaitaa ;

Cai, Shuting S. ;

Dillen, Carly A. ;

Liu, Haiyun ;

Miller, Robert J. ;

Ashbaugh, Alyssa G. ;

Uppal, Angad S. ;

Oyoshi, Michiko K. ;

Malhotra, Nidhi ;

Hoff, Sabine ;

Garza, Luis A. ;

Kong, Heidi H. ;

Segre, Julia A. ;

Geha, Raif S. ;

Miller, Lloyd S. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (04) :1426-+

[3]

Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]

[4] Substance P activates Mas-related G protein-coupled receptors to induce itch [J].

Azimi, Ehsan ;

Reddy, Vemuri B. ;

Seadi Pereira, Paula Juliana ;

Talbot, Sebastien ;

Woolf, Clifford J. ;

Lerner, Ethan A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (02) :447-+

[5] Dual action of neurokinin-1 antagonists on Mas-related GPCRs [J].

Azimi, Ehsan ;

Reddy, Vemuri B. ;

Shade, Kai-Ting C. ;

Anthony, Robert M. ;

Talbot, Sebastien ;

Pereira, Paula Juliana Seadi ;

Lerner, Ethan A. .

JCI INSIGHT, 2016, 1 (16)

[6] Epidemiology of atopic dermatitis in adults: Results from an international survey [J].

Barbarot, S. ;

Auziere, S. ;

Gadkari, A. ;

Girolomoni, G. ;

Puig, L. ;

Simpson, E. L. ;

Margolis, D. J. ;

de Bruin-Weller, M. ;

Eckert, L. .

ALLERGY, 2018, 73 (06) :1284-1293

[7] Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience [J].

Bardazzi, Federico ;

Magnano, Michela ;

Campanati, Anna ;

Loconsole, Francesco ;

Carpentieri, Antonio ;

Potenza, Concetta ;

Bernardini, Nicoletta ;

Di Lernia, Vito ;

Carrera, Carlo ;

Raone, Beatrice ;

Patrizi, Annalisa ;

Loi, Camilla .

ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) :989-990

[8] HUMAN EPIDERMAL LANGERHANS CELLS EXPRESS THE HIGH-AFFINITY RECEPTOR FOR IMMUNOGLOBULIN-E (FC-EPSILON-RI) [J].

BIEBER, T ;

DELASALLE, H ;

WOLLENBERG, A ;

HAKIMI, J ;

CHIZZONITE, R ;

RING, J ;

HANAU, D ;

DELASALLE, C .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (05) :1285-1290

[9] Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis [J].

Bieber, Thomas ;

Simpson, Eric L. ;

Silverberg, Jonathan I. ;

Thaci, Diamant ;

Paul, Carle ;

Pink, Andrew E. ;

Kataoka, Yoko ;

Chu, Chia-Yu ;

DiBonaventura, Marco ;

Rojo, Ricardo ;

Antinew, Jeremias ;

Ionita, Ileana ;

Sinclair, Rodney ;

Forman, Seth ;

Zdybski, Jacek ;

Biswas, Pinaki ;

Malhotra, Bimal ;

Zhang, Fan ;

Valdez, Hernan .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12) :1101-1112

[10] The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study [J].

Bissonnette, R. ;

Maari, C. ;

Forman, S. ;

Bhatia, N. ;

Lee, M. ;

Fowler, J. ;

Tyring, S. ;

Pariser, D. ;

Sofen, H. ;

Dhawan, S. ;

Zook, M. ;

Zammit, D. J. ;

Usansky, H. ;

Denis, L. ;

Rao, N. ;

Song, T. ;

Pavel, A. B. ;

Guttman-Yassky, E. .

BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (04) :733-742

← 1 2 3 4 5 6 7 8 9 →